Donald L. Kaminsky, M.D., a board certified, private practitioner practicing in New York City, has specialized in the treatment of immunodeficency and HIV disease since 1980. As an Attending Physician in Medicine and Infectious Diseases at Beth Israel Medical Center in Manhattan, Dr. Kaminsky was and continues to be an integral part of the AIDS service at the Medical Center.

Dr. Kaminsky received his undergraduate degree from the University of Vermont. His Doctor of Medicine was received from George Washington University Medical School in Washington, D.C. His medical internship, residency and fellowship in Infectious Diseases were all done at Beth Israel Medical Center in New York. He is a Clinical Instructor at the Albert Einstein College of Medicine and at Beth Israel Medical Center.

Currently, Dr. Kaminsky is a member of: The American College of Physicians, Society for Microbiology, Infectious Disease Society, International AIDS Society, Association of Physicians in AIDS Medicine, New York AIDS Coalition, New York Society of Infectious Diseases, International Society of Travel Medicine, and New York Society of Tropical Medicine. In addition he served as a working member of the AIDS Planning Committee at Beth Israel Medical Center, and was the Co-Administrator for the Alan Schnurmacher Fund.

Dr. Kaminsky has published in the Annals of Internal Medicine and The American Journal of Gastroenterology. In 1983, he presented a program and abstract at the twenty-third Interscience Conference on Anti-microbial Agents and Chemotherapy.

While in private practice, Dr. Kaminsky has been active in numerous drug studies dealing with HIV and immunodeficiency. These studies include: Retrovir (AZT), r-Hu EPO treatment protocol No. 188-083, Epivir (3TC) GR1O9714X (Lamivudine), Crixivan (MK - 639, Indinavir Sulfate) Advanced AIDS program, Viracept (nelfinavir mesylate), Preveon (adefovir dipivoxil), Abacavir (1592U89), Zerit (D4T), and Interferon.